Kewaunee Scientific (KEQU) Cost of Revenue (2010 - 2026)

Kewaunee Scientific's Cost of Revenue history runs 17 years deep, the most recent figure standing at $50.2 million for Q2 2026.

• On a quarterly basis, Cost of Revenue fell 5.56% year-over-year to $50.2 million in Q2 2026; TTM through Apr 2026 was $201.6 million, a 17.45% increase from a year earlier, with the FY2026 full-year figure at $201.6 million, up 17.45% from the prior year.
• Cost of Revenue retreated to $50.2 million in Q2 2026 per KEQU's latest filing, from $50.9 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $53.1 million in Q2 2025 and bottomed at $33.8 million in Q4 2024.
• The 5-year median for Cost of Revenue is $43.8 million (2022), against an average of $43.6 million.
• Across the five-year window, Cost of Revenue sank 31.18% in 2024 and soared 48.99% in 2025, its largest moves.
• Year by year, Cost of Revenue stood at $45.9 million in 2022, then dropped by 19.39% to $37.0 million in 2023, then declined by 8.54% to $33.8 million in 2024, then surged by 48.99% to $50.4 million in 2025, then declined by 0.44% to $50.2 million in 2026.
• Per Business Quant, the three latest KEQU Cost of Revenue figures stand at $50.2 million (Q2 2026), $50.9 million (Q1 2026), and $50.4 million (Q4 2025).